Atanas G. Atanasov is Principle Investigator of Ludwig Boltzmann Institute for Digital Health and Patient Safety (LBI-DHPS) at Medical University of Vienna (Austria), Professor of IGAB PAS (Poland), and Editor-in-Chief of Current Research in Biotechnology (#CRBIOTECH) and Exploration of Digital Health Technologies (#ExplorDHT).
Dr Atanasov holds MSc in Biotechnology (from the University of Sofia, Bulgaria), PhD in Biochemistry (from the University of Bern, Switzerland), and Habilitation (Dr. habil. / PD) in Pharmaceutical Biology (from the University of Vienna, Austria). He has published >300 papers in the areas of Molecular Medicine, Digital Health, Open Innovation, Biotechnology, Natural Products, Nutrition, Science Communication, and Molecular Pharmacology. Moreover, Dr Atanas G. Atanasov is ranked as a Cross-Field Highly Cited Researcher (by Clarivate) since 2021, is included in the Stanford University’s World’s Top 2% Scientists list, and is a distinguished promoter of digital science communication (including use of social media, e.g., a >100 000-followers X (formerly Twitter)) and open innovation (e.g., through the executive leadership of open innovation platforms focused on Digital Health and Patient Safety (#DHPSP) and on Natural Product Research (#INPST)).